CA Intermediate · Advanced Accounting · AS 26 Intangible Assets
Kaveri Pharma Ltd incurred Rs 18 lakh on a research phase of a new drug formulation and Rs 30 lakh on the development phase after all AS 26 recognition criteria were met. How much should be capitalised as an intangible asset?
Rs 30 lakh is capitalised. Under AS 26, research phase expenditure is recognised as an expense when incurred, while development expenditure is capitalised once the recognition criteria are demonstrated. The Rs 18 lakh research cost is therefore charged to profit and loss.
- ARs 48 lakh
- BRs 30 lakhCorrect
- CRs 18 lakh
- DNil
Explanation
Research phase expenditure is always expensed when incurred. Only development expenditure incurred after the criteria are demonstrated is capitalised, so Rs 30 lakh is capitalised. Rs 48 lakh wrongly capitalises research cost as well.
Did you get it right without looking?
One question tells you little. A timed set on AS 26 Intangible Assets shows your real accuracy, how long you take and where you lose marks.
More AS 26 Intangible Assets questions
- Kaveri Pharma Ltd. acquired a patent on 1 April 2023 for Rs 40,00,000 with a legal life of 10 years. Management expects it to generate benef…
- Ishaan Ltd acquired a patent on 1 April 2023 for Rs 80 lakh, with a useful life of 8 years and no residual value, amortised straight-line. O…
- Under AS 26, which of the following expenditures incurred by Narmada Retail Ltd. is recognised as an expense when incurred rather than as pa…
- Mehta Textiles Ltd bought a trademark by paying Rs 9,00,000 purchase price, Rs 50,000 non-refundable import duty, Rs 30,000 legal fees for r…
- Rao Software Ltd began developing an accounting package. Expenditure: Rs 8 lakh from April to June (before criteria were met), and Rs 6 lakh…
- Veda Textiles Ltd. incurred Rs 8 lakh on a research phase to find a new dye formula and Rs 12 lakh on a subsequent development phase, after …